NCT00005884View on ClinicalTrials.gov

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

December 31, 2000

Conditions
Non-melanomatous Skin Cancer
Interventions
DRUG

eflornithine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00005884 - Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer | Biotech Hunter | Biotech Hunter